Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 12—December 2018
Research

Crimean-Congo Hemorrhagic Fever Virus, Mongolia, 2013–2014

Matthew A. Voorhees, Susana L. Padilla, Dulamjav Jamsransuren, Jeffrey W. Koehler, Korey L. Delp, Dolgorkhand Adiyadorj, Uyanga Baasandagwa, Battsetseg Jigjav, Scott P. Olschner, Timothy D. Minogue, and Randal J. SchoeppComments to Author 
Author affiliations: United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA (M.A. Voorhees, S.L. Padilla, J.W. Koehler, K.L. Delp, S.P. Olschner, T.D. Minogue, R.J. Schoepp); Ministry of Health National Center for Zoonotic Diseases, Ulaanbaatar, Mongolia (D. Jamsransuren, D. Adiyadorj, U. Baasandagwa, B. Jigjav)

Main Article

Table 3

CCHFV neutralization capacity of human serum samples with and without evidence of CCHFV IgG by ELISA, Mongolia, 2013–2014*

Sample no. ELISA OD PRNT50 probit titer† PRNT80 probit titer†
376 0 <10 <10
674 0 <10 <10
272 0 89 27
822 0 <10 <10
408 0 19 11
868 0.01 <10 <10
85 0.02 <10 <10
867 0.21 <10 <10
862 0.31 26 <10
297 0.38 29 10
41 0.40 33 <10
667 0.42 15 <10
823 0.43 <10 <10
115 0.64 <10 <10
101 0.87 <10 <10
131 0.97 10 <10
870 1.18 127 45
81 1.18 40 20
97 1.28 20 <10

*Samples positive for CCHFV IgG by ELISA were those with ODs >0.20. OD, optical density; PRNT50, plaque assay neutralization test with 50% of the plaque assay dose reduced; PRNT80, plaque assay neutralization test with 80% of the plaque assay dose reduced.
†The titer reported is the inverse of the highest serum sample dilution that neutralized the appropriate percentage of virus.

Main Article

Page created: November 20, 2018
Page updated: November 20, 2018
Page reviewed: November 20, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external